Enovis Corporation

    Jurisdiction
    United States
    LEI
    635400OP2DYYYMOIYL17
    ISIN
    US1940145022 (ENOV)
    Sectors
    1. Industrials
    2. Industrial - Machinery

    Scores

    Fair value (Benjamin Graham formula)
    N/A
    Financial strength (Piotroski F-Value)
    4 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    2 / 7

    Profile

    Enovis Corporation operates as a medical technology company worldwide. Read full profile

    Fundamentals

    Net revenue
    €1.87B
    Gross margin
    55.6%
    EBIT
    -€672.57M
    EBIT margin
    -36.0%
    Net income
    -€705.79M
    Net margin
    -37.8%

    Statement period: - (published )

    Estimates

    Fiscal Year Net revenue Net income
    €2.05B +9.6% €174.20M -124.7%
    €2.18B +6.7% €205.61M +18.0%
    N/A N/A

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Dividends

    No dividend payouts

    Analyst ratings

    No analyst ratings available

    Insider Transactions

    Name Title Transaction Date Shares Price Value
    Tandy Bradley J SVP and Chief Legal Officer +3.2K $31.41 +$100.51K
    BERRY PHILLIP BENJAMIN (BEN) SVP, Chief Financial Officer +2.5K $29.71 +$74.28K
    PRYOR DANIEL A EVP, Strategy & Business Dev. +10K $28.90 +$289.00K

    Earnings Calls

    Earnings Calls

    Latest earnings call: May 2, 2024 (Q1 2024)

    Add to watchlist

    Notifications